How to measure the transmetallation of a gadolinium complex

Contrast Media and Molecular Imaging

Volumn 5, Issue 6, 2010, Pages 305-308

  Laurent, S ^a   Vander Elst, L ^a   Henoumont, C ^a   Muller, R N ^a  

^a UNIVERSITY OF MONS   (Belgium)

Author keywords

Contrast agents; Gd complexes; Kinetic stability; Thermodynamic stability; Transmetallation

Indexed keywords

BUFFER; CALCIUM ION; ECHOVIST; GADODIAMIDE; GADOLINIUM PENTETATE; GADOTERATE MEGLUMINE; GADOTERIDOL; GADOXETIC ACID; ZINC ACETATE; ZINC CHLORIDE; ZINC ION;

ARTICLE; DRUG SOLUBILITY; DRUG STABILITY; METALLATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; THERMODYNAMICS;

CONTRAST MEDIA; GADOLINIUM; IONS; LIGANDS; MAGNETIC RESONANCE IMAGING; ORGANOMETALLIC COMPOUNDS; PROTONS; THERMODYNAMICS; WATER; ZINC;

EID: 78650664558     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.388     Document Type: Article

References (19)

1. Yoo B, Pagel MD. An overview of responsive MRI contrast agents for molecular imaging. Frontiers in Bioscience 2008; 13: 1733- 1752.
2. Frullano L, Meade TJ. Multimodal MRI contrast agents. J Biol Inorg Chem 2007; 12: 939-949.
3. Geraldes CFGC, Laurent S. Classification and basic properties of contrast agents for magnetic resonance imaging. Contrast Med Mol Imag 2009; 4: 1-23.
4. Hermann P, Kotek J, Kubícek V, Lukes I. Gadolinium(III) complexes as MRI contrast agents: ligand design and properties of the complexes. Dalton Trans 2008; 23: 3027-3047.
5. Puttagunta NR, Gibby WA, Puttagunta VL. Comparative transmetallation kinetics and thermodynamic stability of gadolinium-DTPA bis-glucosamide. Invest Radiol 1996; 31: 619-624.
6. Puttagunta NR, Gibby WA, Puttagunta VL. Human in vivo comparative study of zinc and copper transmetallation after administration of magnetic resonance imaging contrast agents. Invest. Radiol. 1996; 31: 739-742.
7. Corot C, Idee J-M, Hentsch A-M, Santus R, Mallet C, Goulas V, Bonnemain B, Meyer D. Structure-activity relationship of macrocyclic and linear gadolinium chelates: investigation of transmetallation effect on the zinc-dependent metallopeptidase angiotensin-converting enzyme. J Magn Reson Imag 1998; 8: 695-702.
8. Corot C, Hentsch A-M, Curtelin L. Interaction of gadolinium complexes with metal-dependent biological systems. Invest Radiol 1994; 29(suppl2): S164-S167.
9. Tweedle MF, Hagan JJ, Kumar K, Mantha S, Chang CA. Reaction of gadolinium chelates with endogenously available ions. Magn Reson Imag 1991; 9: 409-415.
10. Laurent S, Vander Elst L, Copoix F, Muller RN. Stability of MRI paramagnetic contrast media. A proton relaxometric protocol for transmetallation assessment. Invest Radiol 2001; 36: 115-122.
11. Brücher E. Kinetic stabilities of gadolinium(III) chelates used as MRI contrast agents. Top Curr Chem 2002; 221: 103-122.
12. Port M, Idée J-M, Medina C, Robic C, Sabatou M, Corot C. Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review. BioMetals 2008; 21: 469-490.
13. Wiginton CD, Kelly B, Oto A, Jesse M, Aristimuno P, Ernst R, Chaljub G. Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue. Am J Roentgenol 2008; 190: 1060-1068.
14. Künnemeyer J, Terborg L, Nowak S, Scheffer A, Telgmann L, Tokmak F, Günsel A, Wiesmüller G, Reichelt S, Karst U. Speciation analysis of gadolinium-based MRI contrast agents in blood plasma by hydrophilic interaction chromatography/electrospray mass spectrometry. Anal Chem 2008; 80(21): 8163-8170.
15. Frenzel T, Lengsfeld P, Schirmer H, Hütter J, Weinmann H-J. Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37°C. Invest Radiol 2008; 43(12): 817-828.
16. Laurent S, Vander Elst L, Muller RN. Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents. Contrast Med Mol Imag 2006; 1(3): 128-137.
17. Wedeking P, Kumar K, Tweedle MF. Dissociation of gadolinium chelates in mice: relationship to chemical characteristics. Magn Reson Imag 1992; 10: 641-648.
18. Tweedle MF. Physicochemical properties of gadoteridol and other magnetic resonance contrast agents. Invest Radiol 1992; 27(suppl 1): S2-S6.
19. Vander Elst L, Raynal I, Port M, Tisnès P, Muller RN. In vitro relaxometric and luminescence characterization of P792 (Gadomelitol, Vistarem®), an efficient and rapid clearance blood pool MRI contrast agent. Eur J Inorg Chem 2005; 1142-1148.